아시아태평양의 응고 시장 예측(-2030년) : 지역별 분석 - 적응 질환별, 유형별, 제공 품목별, 기술별, 최종사용자별

The Asia Pacific coagulation market was valued at US$ 889.52 million in 2022 and is expected to reach US$ 1,672.49 million by 2030; it is estimated to grow at a CAGR of 8.2% from 2022 to 2030.

Growing Organic and Inorganic Strategies by Key Market Players Fuel Asia Pacific Coagulation Market

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

• In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.
• In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.
• In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.
• In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex's automated blood coagulation analyzer, such as the CN-3000 and CN-6000.
• In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation Offerings. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Asia Pacific Coagulation Market Overview

The Asia Pacific coagulation market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising geriatric population, increasing incidences of cardiovascular diseases, growing prevalence of bleeding disorders, development of distribution networks, and advancements in coagulation analyzers.

According to an article published in the National Center for Biotechnology Information (NCBI), "Cardiovascular Health and Diseases in China 2022," cardiovascular diseases (CVD) are the cause of ~47% and ~44% of all deaths in rural and urban regions in China, respectively. In 2020, nearly 330 million patients are predicted to suffer from CVD in China. According to a research study published in The Lancet, CVDs cause ~4 million deaths each year in China. CVD patients have elevated levels of coagulation factors in their bodies. Hence, an upsurge in the prevalence of CVDs is fueling the growth of the coagulation market in China.

Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Coagulation Market Segmentation

The Asia Pacific coagulation market is segmented based on disease indication, type, offering, technology, end user, and country.

Based on disease indication, the Asia Pacific coagulation market is segmented into vitamin k deficiency, liver disease, disseminated intravascular coagulation and pulmonary embolism, development of circulating anticoagulants, hemophilia, von willebrand's disease, and others. The liver disease segment held the largest Asia Pacific coagulation market share in 2022.

Based on type, the Asia Pacific coagulation market is bifurcated into clinical laboratory analysers and point-of-care testing analyzers. The clinical laboratory analysers segment held a larger Asia Pacific coagulation market share in 2022. Clinical laboratory analysers segment is further subsegmented into controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others.

In terms of offering, the Asia Pacific coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger Asia Pacific coagulation market share in 2022. Diagnosis segment is further subsegmented into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, d-dimmer testing, platelets function testing, and others. Treatment segment is further subsegmented into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin k supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapy, catheter-assisted thrombus removal, and others.

By technology, the Asia Pacific coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. The optical technology segment held the largest Asia Pacific coagulation market share in 2022.

By end user, the Asia Pacific coagulation market is segmented into clinical laboratories, hospitals, and others. The hospitals segment held the largest Asia Pacific coagulation market share in 2022.

Based on country, the Asia Pacific coagulation market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific coagulation market in 2022.

F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Horiba Ltd; ImproGen Diagnostik Kimya San & Tic Ltd.Sti., Siemens Healthineers AG; Sysmex Corp; and Transasia Bio-Medicals Ltd are some of the leading companies operating in the Asia Pacific coagulation market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Asia Pacific Coagulation Market - Key Industry Dynamics

• 4.1 Key Market Drivers:
  • 4.1.1 Increasing Prevalence of Blood Disorders
  • 4.1.2 Rising Prevalence of Cardiovascular Diseases
• 4.2 Market Restraints
  • 4.2.1 High Costs Associated with Coagulation Analyzers
• 4.3 Market Opportunities
  • 4.3.1 Growing Organic and Inorganic Strategies by Key Market Players
• 4.4 Future Trends
  • 4.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
• 4.5 Impact Analysis

5. Coagulation Market - Asia Pacific Market Analysis

• 5.1 Asia Pacific Coagulation Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Disease Indication

• 6.1 Overview
• 6.2 Asia Pacific Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
• 6.3 Vitamin K Deficiency
  • 6.3.1 Overview
  • 6.3.2 Vitamin K Deficiency: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Liver Disease
  • 6.4.1 Overview
  • 6.4.2 Liver Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
  • 6.5.1 Overview
  • 6.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.6 Development of Circulating Anticoagulant
  • 6.6.1 Overview
  • 6.6.2 Development of Circulating Anticoagulant: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.7 Hemophilia
  • 6.7.1 Overview
  • 6.7.2 Hemophilia: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.8 Von Willebrand's Disease
  • 6.8.1 Overview
  • 6.8.2 Von Willebrand's Disease: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 6.9 Others
  • 6.9.1 Overview
  • 6.9.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Type

• 7.1 Overview
• 7.2 Asia Pacific Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
• 7.3 Clinical Laboratory Analyzers
  • 7.3.1 Overview
  • 7.3.2 Clinical Laboratory Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.2.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzers
• 7.4 Point-of-Care Testing Analyzers
  • 7.4.1 Overview
  • 7.4.2 Point-of-Care Testing Analyzers: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Offering

• 8.1 Overview
• 8.2 Asia Pacific Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
• 8.3 Diagnosis
  • 8.3.1 Overview
  • 8.3.2 Diagnosis: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.3.2.1 Asia Pacific Coagulation Market, by Diagnosis
• 8.4 Treatment
  • 8.4.1 Overview
  • 8.4.2 Treatment: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
    • 8.4.2.1 Asia Pacific Coagulation Market, by Treatment

9. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by Technology

• 9.1 Overview
• 9.2 Asia Pacific Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
• 9.3 Optical Technology
  • 9.3.1 Overview
  • 9.3.2 Optical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Mechanical Technology
  • 9.4.1 Overview
  • 9.4.2 Mechanical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Electrochemical Technology
  • 9.5.1 Overview
  • 9.5.2 Electrochemical Technology: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Coagulation Market - Revenue and Forecast to 2030 - by End User

• 10.1 Overview
• 10.2 Asia Pacific Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
• 10.3 Clinical Laboratories
  • 10.3.1 Overview
  • 10.3.2 Clinical Laboratories: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 10.4 Hospitals
  • 10.4.1 Overview
  • 10.4.2 Hospitals: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)
• 10.5 Others
  • 10.5.1 Overview
  • 10.5.2 Others: Asia Pacific Coagulation Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Coagulation Market - Country Analysis

• 11.1 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
  • 11.1.1 Asia Pacific Coagulation Market by Country
    • 11.1.1.1 China
      • 11.1.1.1.1 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.1.2 China Coagulation Market, by Disease Indication
      • 11.1.1.1.3 China Coagulation Market, by Type
      • 11.1.1.1.3.1 China Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.1.4 China Coagulation Market, by Offering
      • 11.1.1.1.4.1 China Coagulation Market, by Diagnosis
      • 11.1.1.1.4.2 China Coagulation Market, by Treatment
      • 11.1.1.1.5 China Coagulation Market, by Technology
      • 11.1.1.1.6 China Coagulation Market, by End User
    • 11.1.1.2 Japan
      • 11.1.1.2.1 Overview
      • 11.1.1.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.2.3 Japan Coagulation Market, by Disease Indication
      • 11.1.1.2.4 Japan Coagulation Market, by Type
      • 11.1.1.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.2.5 Japan Coagulation Market, by Offering
      • 11.1.1.2.5.1 Japan Coagulation Market, by Diagnosis
      • 11.1.1.2.5.2 Japan Coagulation Market, by Treatment
      • 11.1.1.2.6 Japan Coagulation Market, by Technology
      • 11.1.1.2.7 Japan Coagulation Market, by End User
    • 11.1.1.3 India
      • 11.1.1.3.1 Overview
      • 11.1.1.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.3.3 India Coagulation Market, by Disease Indication
      • 11.1.1.3.4 India Coagulation Market, by Type
      • 11.1.1.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.3.5 India Coagulation Market, by Offering
      • 11.1.1.3.5.1 India Coagulation Market, by Diagnosis
      • 11.1.1.3.5.2 India Coagulation Market, by Treatment
      • 11.1.1.3.6 India Coagulation Market, by Technology
      • 11.1.1.3.7 India Coagulation Market, by End User
    • 11.1.1.4 Australia
      • 11.1.1.4.1 Overview
      • 11.1.1.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.4.3 Australia Coagulation Market, by Disease Indication
      • 11.1.1.4.4 Australia Coagulation Market, by Type
      • 11.1.1.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.4.5 Australia Coagulation Market, by Offering
      • 11.1.1.4.5.1 Australia Coagulation Market, by Diagnosis
      • 11.1.1.4.5.2 Australia Coagulation Market, by Treatment
      • 11.1.1.4.6 Australia Coagulation Market, by Technology
      • 11.1.1.4.7 Australia Coagulation Market, by End User
    • 11.1.1.5 South Korea
      • 11.1.1.5.1 Overview
      • 11.1.1.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.5.3 South Korea Coagulation Market, by Disease Indication
      • 11.1.1.5.4 South Korea Coagulation Market, by Type
      • 11.1.1.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.5.5 South Korea Coagulation Market, by Offering
      • 11.1.1.5.5.1 South Korea Coagulation Market, by Diagnosis
      • 11.1.1.5.5.2 South Korea Coagulation Market, by Treatment
      • 11.1.1.5.6 South Korea Coagulation Market, by Technology
      • 11.1.1.5.7 South Korea Coagulation Market, by End User
    • 11.1.1.6 Rest of Asia Pacific
      • 11.1.1.6.1 Overview
      • 11.1.1.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
      • 11.1.1.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
      • 11.1.1.6.4 Rest of Asia Pacific Coagulation Market, by Type
      • 11.1.1.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
      • 11.1.1.6.5 Rest of Asia Pacific Coagulation Market, by Offering
      • 11.1.1.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
      • 11.1.1.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
      • 11.1.1.6.6 Rest of Asia Pacific Coagulation Market, by Technology
      • 11.1.1.6.7 Rest of Asia Pacific Coagulation Market, by End User

12. Coagulation Market-Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in the Coagulation Market
• 12.3 Inorganic Growth Strategies
  • 12.3.1 Overview
• 12.4 Organic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 Siemens Healthineers AG
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 ImproGen Diagnostik Kimya San. & Tic. Ltd.Sti.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Sysmex Corp
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 F. Hoffmann-La Roche Ltd
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Genrui Biotech Co., Ltd.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 Transasia Bio-Medicals Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 Horiba Ltd.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments

14. Appendix

• 14.1 About Us
• 14.2 Glossary of Terms